Strains |
|
|
E. coli
|
|
|
DH5α |
F− (φ80dlacZ ΔM15) Δ(lacZYA-argF)U169 recA1 endA1 hsdR17(rK− mK+) supE44 λ−thi-1 gyrA relA
|
16 |
BL21(DE3) |
F−ompT rB− mB−1 DE3 |
45 |
BW25141 |
F− Δ(araD-araB)567 ΔlacZ4787(::rrnB-3) lacIp-4000(lacIq) Δ(phoB-phoR) 580 λ−galU95 ΔuidA3::pir+recA1 endA9(del-ins)::FRT rph-1 Δ(rhaD-rhaB)568 rrnB-3 hsdR514
|
14 |
EC100DTMpir-116
|
F−mcrA Δ(mrr-hsdRMS-mcrBC) ϕ80dlacZΔM15 ΔlacX74 recA1 endA1 araD139 Δ(ara leu)7697 galU galK λ−rpsL nupG pir-116(DHFR) |
Epicentre Technologies |
C. jejuni
|
|
|
NCTC 11168 |
Clinical isolate used for genome sequencing |
34 |
81-176 |
Clinical isolate |
26 |
M1 |
Environmental isolate |
D. G. Newell, gift |
Plasmids |
|
|
pET29b+C9 |
pET29b+ carrying Q131R and E137K mutations in Himar1 transposase |
29 |
pRY111 |
Source of campylobacter cat cassette |
53 |
pAJG39 |
pEnterprise2 with 0.6-kb fragment harbouring oriR6Kγ from EZ::TN<R6Kγori/KAN-2> cloned into the SalI site |
This study |
pAJG40-134 |
pAJG39 with 0.1-kb fragment harbouring an individual Holden DNA tag cloned into the PstI site |
This study |
pEnterprise2 |
pUC19 with 1.5-kb fragment harbouring cat and transposon from pEnterprise, cloned as a PmeI fragment into blunt-ended EcoRI and HindIII sites |
D. R. Hendrixson, gift; reference 17
|
EZ::TN<R6Kγori/KAN-2> |
Source of the R6Kγ origin of replication |
Epicentre Technologies |